专家文章 | 邱正堂

搜索
登录

热心肠智库专家文章 | 邱正堂

2023

CARecommendations and guidelines for endoscope reprocessing: Current position statement of digestive endoscopic society of Taiwan

J MICROBIOL IMMUNOL, 10.1016/j.jmii.2023.12.001

CAArtificial intelligence-aided diagnostic imaging: A state-of-the-art technique in precancerous screening

J GASTROEN HEPATOL, 10.1111/jgh.16429

2022

CAGut Colonization and Antibiotic-Associated Diarrhea by Clostridium innocuum in Children and Adults

Clin Infect Dis, 10.1093/cid/ciac696

2021

CAThe effectiveness and safety of vedolizumab induction for moderate to severe ulcerative colitis for Asia patient: A real practice observational study

Taiwan yi zhi, 10.1016/j.jfma.2021.11.012

CAImplementation of fecal microbiota transplantation in a medical center for recurrent or refractory Clostridioides difficile infection and report of preliminary outcome

BIOMED J, 10.1016/j.bj.2021.06.001

CAMultidrug resistance: The clinical dilemma of refractory Helicobacter pylori infection

J MICROBIOL IMMUNOL, 10.1016/j.jmii.2021.03.006

2020

CAFecal microbiota transplantation and donor screening for Clostridioides difficile infection during COVID-19 pandemic

Taiwan yi zhi, 10.1016/j.jfma.2020.07.028

CARescue therapy with rifabutin regimen for refractory Helicobacter pylori infection with dual drug-resistant strains

BMC Gastroenterol, 10.1186/s12876-020-01370-4

CADrug-Resistant Bacteremia after Fecal Microbiota Transplant

NEJM, 10.1056/NEJMc2002496#sa2

2019

CAEfficacy of dexlansoprazole-based triple therapy for Helicobacter pylori infections

THER ADV GASTROENTER, 10.1177/1756284819870960

CAEfficacy of dexlansoprazole-based triple therapy for Helicobacter pylori infections

THER ADV GASTROENTER, 10.1177/1756284819870960

CAEfficacy of dexlansoprazole-based triple therapy for Helicobacter pylori infections

THER ADV GASTROENTER, 10.1177/1756284819870960

CAEfficacy of dexlansoprazole-based triple therapy for Helicobacter pylori infections

THER ADV GASTROENTER, 10.1177/1756284819870960

CAEfficacy of dexlansoprazole-based triple therapy for Helicobacter pylori infections

THER ADV GASTROENTER, 10.1177/1756284819870960

CAEfficacy of dexlansoprazole-based triple therapy for Helicobacter pylori infections

THER ADV GASTROENTER, 10.1177/1756284819870960

CAEfficacy of dexlansoprazole-based triple therapy for Helicobacter pylori infections

THER ADV GASTROENTER, 10.1177/1756284819870960

CAEfficacy of dexlansoprazole-based triple therapy for Helicobacter pylori infections

THER ADV GASTROENTER, 10.1177/1756284819870960

CAEfficacy of dexlansoprazole-based triple therapy for Helicobacter pylori infections

THER ADV GASTROENTER, 10.1177/1756284819870960

CAEfficacy of dexlansoprazole-based triple therapy for Helicobacter pylori infections

THER ADV GASTROENTER, 10.1177/1756284819870960

CAEfficacy of dexlansoprazole-based triple therapy for infections

THER ADV GASTROENTER, 10.1177/1756284819870960